Transparency · openFDA

Complete response letters

FDA's letters telling drug and biologic applicants why an application was not approved as submitted. 458 records; openFDA updated it 2026-11-10. About this dataset

Newest records

Later approved?
  • Approved309
  • Unapproved149
  • CELLTRION, Inc. · BLA 761377

    i Lk YN U.S. FOOD & DRUG ADMINISTRATION BLA 761377 COMPLETE RESPONSE CELLTRION, Inc. c/o Parexel International Attention: Ally Danta Regulatory Affairs Consultant 2520 Meridian Parkway, Suite 100 Dur…

    COMPLETE RESPONSEUnapproved
  • AstraZeneca Pharmaceuticals LP · BLA 761451

    Cg YN U.S. FOOD & DRUG ADMINISTRATION BLA 761451 COMPLETE RESPONSE AstraZeneca Pharmaceuticals LP Attention: Osamah Al-Qaysi Associate Regulatory Affairs Director One Medimmune Way Gaithersburg, MD 2…

    COMPLETE RESPONSEUnapproved
  • Aldeyra Therapeutics, Inc. · NDA 216442

    Lg my U.S. FOOD & DRUG Ny, ADMINISTRATION NDA 216442 COMPLETE RESPONSE Aldeyra Therapeutics, Inc. Attention: David Noskowitz Regulatory Affairs Consultant 131 Hartwell Ave., Suite 320 Lexington, MA 0…

    COMPLETE RESPONSEUnapproved
  • Replimune, Inc. · BL 125827

    i Lg YN U.S. FOOD & DRUG ADMINISTRATION Our STN: BL 125827 COMPLETE RESPONSE JULY 21, 2025 Replimune, Inc. Attention: Kari Jeschke 500 Unicorn Park Drive Woburn, MA 01801 Dear Kari Jeschke: Please re…

    COMPLETE RESPONSEUnapproved
  • Accord BioPharma Inc. · BLA 761424

    IN U.S. FOOD & DRUG ADMINISTRATION BLA 761424 COMPLETE RESPONSE Accord BioPharma Inc. Attention: Sabita Nair VP Regulatory Affairs 8041 Arco Corporate Drive, Suite 200 Raleigh, NC 27617 Dear Sabita N…

    COMPLETE RESPONSEUnapprovedCenter for Drug Evaluation and Research
  • Sun Pharmaceutical Industries Limited · NDA 215644

    f ¢ yy U.S. FOOD & DRUG ADMINISTRATION Net NDA 215644 COMPLETE RESPONSE Sun Pharmaceutical Industries Limited C/O: Sun Pharmaceutical Industries, Inc. Attention: Umesh Pai, US Agent 2 Independence Wa…

    COMPLETE RESPONSEUnapproved
  • Saol International Development Limited · NDA 218679

    ADMINISTRATION i Lk YN U.S. FOOD & DRUG NDA 218679 COMPLETE RESPONSE Saol International Development Limited % Saol Therapeutics Inc Attention: Allison Lowry Head of Regulatory 1000 Holcomb Woods Park…

    COMPLETE RESPONSEUnapproved
  • Dr. Reddy’s Laboratories SA · BLA 761376

    ADMINISTRATION i Lk YN U.S. FOOD & DRUG BLA 761376 COMPLETE RESPONSE Dr. Reddy’s Laboratories SA c/o Parexel International Attention: Ally Danta Regulatory Affairs Consultant 541 Church at North Hill…

    COMPLETE RESPONSEUnapprovedCenter for Drug Evaluation and Research
  • Teva Pharmaceuticals, Inc. · BLA 761385

    i Lk YN U.S. FOOD & DRUG ADMINISTRATION BLA 761385 COMPLETE RESPONSE Teva Pharmaceuticals, Inc. Attention: David DeCicco Director, Global Biosimilar Regulatory Affairs 145 Brandywine Parkway West Che…

    COMPLETE RESPONSEUnapprovedCenter tor Drug Evaluation and Research
  • Telix Pharmaceuticals (US) Inc. · NDA 218592

    ADMINISTRATION ¢ YN U.S. FOOD & DRUG NDA 218592 COMPLETE RESPONSE Telix Pharmaceuticals (US) Inc. Attention: Lara Haddad RPh, RAC Manager, Global Regulatory Affairs 11700 Exit 5 Pkwy Suite 200 Fisher…

    COMPLETE RESPONSEUnapproved
  • PTC Therapeutics, Inc. · NDA 220049

    ADMINISTRATION ¢ YN U.S. FOOD & DRUG NDA 220049 COMPLETE RESPONSE PTC Therapeutics, Inc. Attention: Aparna Geddam, MS Director, Global Regulatory Strategy 500 Warren Corporate Center Drive Warren, NJ…

    COMPLETE RESPONSEUnapproved
  • Stealth BioTherapeutics Inc. · NDA 215244

    i Lk YN U.S. FOOD & DRUG ADMINISTRATION NDA 215244 COMPLETE RESPONSE Stealth BioTherapeutics Inc. Attention: Jim Carr Chief Clinical Development Officer 123 Highland Avenue, Suite 201 Needham, MA 024…

    COMPLETE RESPONSEUnapproved
  • Elevar Therapeutics, Inc. · NDA 216586

    ind U.S. FOOD & DRUG ADMINISTRATION q NDA 216586 COMPLETE RESPONSE Elevar Therapeutics, Inc. Attention: Young-Sil (Anna) Yim Senior Director, Regulatory Affairs One Bridge Plaza, Suite 850 Fort Lee,…

    COMPLETE RESPONSEUnapproved
  • Hospira, Inc. · NDA 219112

    a g PN U.S. FOOD & DRUG ADMINISTRATION NDA 219112 COMPLETE RESPONSE Hospira, Inc. Attention: Arman Nolledo Regulatory Affairs Manager 275 N Field Dr, D-389 BLDG H2 Lake Forest, IL 60045 Dear Arman No…

    COMPLETE RESPONSEUnapproved
  • Outlook Therapeutics, Inc. · BLA 761320

    Lg my U.S. FOOD & DRUG Ny, ADMINISTRATION BLA 761320 COMPLETE RESPONSE Outlook Therapeutics, Inc. Attention: Jennifer Kissner, PhD Executive Vice President 111 South Wood Avenue Unit #100 Iselin, NJ…

    COMPLETE RESPONSEUnapproved
  • Shanghai Auzone Biological Technology Co., Ltd. · NDA 219846

    IN U.S. FOOD & DRUG ADMINISTRATION NDA 219846 COMPLETE RESPONSE Shanghai Auzone Biological Technology Co., Ltd. c/o WuXi AppTec Attention: Janet R Rea Regulatory Consultant 23 Woodland Dr. Newport, W…

    COMPLETE RESPONSEUnapprovedCenter for Drug Evaluation and Research
  • Biogen, Inc. · NDA 209531/S-016

    BN U.S. FOOD & DRUG ADMINISTRATION NDA 209531/S-016 COMPLETE RESPONSE Biogen, Inc. Attention: Charlene Wheeler, MSHS Director, Global Regulatory Sciences 225 Binney Street Cambridge, MA 02142 Dear Ch…

    COMPLETE RESPONSEUnapproved
  • Biohaven Therapeutics, Ltd. · NDA 210862

    ADMINISTRATION ¢ Fy U.S. FOOD & DRUG NDA 210862 COMPLETE RESPONSE Biohaven Therapeutics, Ltd. c/o Biohaven Pharmaceuticals, Inc. Attention: Marianne Frost, MA Senior VP, Regulatory Affairs and Operat…

    COMPLETE RESPONSEUnapproved
  • Accord Healthcare Inc. · NDA 216987

    ADMINISTRATION i Lk YN U.S. FOOD & DRUG NDA 216987 COMPLETE RESPONSE Accord Healthcare Inc. Attention: Sabita Nair, RAC, ASQ-CPGP Vice President-Regulatory Affairs 8041 Arco Corporate Drive, Suite 20…

    COMPLETE RESPONSEUnapprovedCenter for Drug Evaluation and Research
  • GlaxoSmithKline LLC · BLA 761458/Original 2,BLA 761458

    f ¢ PN U.S. FOOD & DRUG “en ADMINISTRATION BLA 761458/Original 2 COMPLETE RESPONSE GlaxoSmithKline LLC Attention: David Colton Director, Global Regulatory Affairs 200 Cambridge Park Drive Cambridge,…

    COMPLETE RESPONSEUnapproved
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.